HomeBiotech

Biotech

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

September 23, 2023

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

September 22, 2023

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

September 22, 2023

Unlocking the Future of Drug Discovery with Artificial Intelligence

Unlocking the Future of Drug Discovery with Artificial Intelligence

September 22, 2023

DNA Sequencing Market size to grow by USD 10.69 billion from 2022 to 2027, North America to account for 37% of market growth – Technavio

DNA Sequencing Market size to grow by USD 10.69 billion from 2022 to 2027, North America to account for 37% of market growth – Technavio

September 22, 2023

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

September 21, 2023

Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors

Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors

September 21, 2023

DRIVING PRECISION MEDICINE FORWARD: BIO-IT WORLD EUROPE CONVENES IN LONDON 29-30 NOVEMBER 2023

DRIVING PRECISION MEDICINE FORWARD: BIO-IT WORLD EUROPE CONVENES IN LONDON 29-30 NOVEMBER 2023

September 21, 2023

Two Cases of Pancreatic Cancer Treatment with CARsgen’s CT041 Published in Journal of Hematology & Oncology

Two Cases of Pancreatic Cancer Treatment with CARsgen’s CT041 Published in Journal of Hematology & Oncology

September 21, 2023

Leucid Bio Granted MHRA Clinical Trial Authorisation for Lateral NKG2D CAR-T Cell Therapy LEU011

Leucid Bio Granted MHRA Clinical Trial Authorisation for Lateral NKG2D CAR-T Cell Therapy LEU011

September 21, 2023

« 1 … 82 83 84 85 86 … 126 »